关于这一集
Discover the fascinating world of medical cannabis and the endocannabinoid system with BrainMender. Tune in bi-weekly as neurologist Dr. Shawn Masia hosts insightful, straightforward discussions into the potential risks and benefits of medical cannabis. Enriched by powerful storytelling, BrainMender explores the endocannabinoid system and its influence on mental and physical health, mood, and overall well-being. Whether you're a medical professional, a patient, or simply curious about medical cannabis, Brainmender will transform your perspective.
Unlock the secrets of your mind and body with BrainMender.
英语
美国
文字稿 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
本播客中的其他单集
The cannabis industry brings in two billion dollars per year. Yet, they are not required to tell you the potential risks or benefits associated with their products. In this episode of BrainMender, neurologist Dr. Shawn Masia dives into the potential risks that come with taking cannabis products s...
The cannabis industry brings in two billion dollars per year. Yet, they are not required to tell you the potential risks or benefits associated with their products. In this episode of BrainMender, neurologist Dr. Shawn Masia dives into the potential risks that come with taking cannabis products s...
On this episode of BrainMender, Dr. Masia welcomes Dr. Peter Bongiorno. Dr. Bongiorno is a naturopathic doctor and works at SohoMD to build our integrative wellness services. Dr. Bongiorno authored "Healing Depression: Integrated Naturopathic and Conventional Treatments", the first comprehensive ...
The Endocannabinoid System plays a key role in our bodies... but you have probably never heard of it. This system wants to bring you toward a helpful center, a balance. But how do YOU get there and what even is it!? Tune in now to neurologist Dr. Shawn Masia as he explains all of this without the...
免责声明: 本页面嵌入的播客和封面图片来自 SohoMD，归其所有者所有，与 Listen Notes, Inc. 无关联，也未获得 Listen Notes, Inc. 背书。
